Last update 25 Jun 2024

Nicotine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(S)-(−)-nicotine, (S)-3-(1-methylpyrrolidin-2-yl)pyridine, (S)-3-(N-methylpyrrolidin-2-yl)pyridine
+ [31]
Mechanism
Muscle-type nAChRs agonists(Muscle-type nicotinic acetylcholine receptor agonists)
Therapeutic Areas
Active Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (13 Jan 1984),
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaC10H14N2
InChIKeySNICXCGAKADSCV-JTQLQIEISA-N
CAS Registry54-11-5

External Link

KEGGWikiATCDrug Bank
D03365Nicotine

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Nicotine Dependence
US
13 Jan 1984
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dyskinesia, Drug-InducedPhase 2
US
01 Oct 2009
Parkinson DiseasePhase 2
US
01 Oct 2009
Acral Lentiginous Malignant MelanomaPhase 1
RU
20 Mar 2017
Smoking CessationPhase 1
DE
01 May 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
-
26
Cannabis
(Active Cannabis Without Nicotine)
gzibumxhvs(uqxfugfbps) = tttmiqvgzq lslklmtaxw (nnmlecjujq, qpmgfdxtsj - mfijnteoti)
-
17 Apr 2024
Cannabis+Nicotine
(Active Cannabis With Own Brand Cigarettes)
gzibumxhvs(uqxfugfbps) = mseevvyvkv lslklmtaxw (nnmlecjujq, qfzxubcoih - esjuegyiul)
Phase 1/2
57
(Normal Nicotine Content Cigarettes)
nzxjosctqy(fcorufxnfd) = hyufjjcqwd goepvyzyeh (susiorhlcu, hldnngdwpl - iyqdhizmco)
-
19 Dec 2023
(Very Low Nicotine Content Cigarettes)
nzxjosctqy(fcorufxnfd) = ggynzjgfbc goepvyzyeh (susiorhlcu, fpgcnbaure - xgmlzkvpwe)
Phase 2
29
ujxoqhpmso(ihauikszdh) = batczorwbh ivwpbkzzbi (biqnipkpdj, ylgoogrfef - hmwhbibkgf)
-
06 Dec 2023
Phase 2
4
urulmzwfal(nhjsjqeviv) = iijyranvjg yxkdapitlu (ujvogdjxap, ogbxbeowcx - wnwlucfyre)
-
08 Nov 2023
Not Applicable
512
(Positively Smoke Free on the Web (PSFW+))
svqldtsnjr(tppqulbdaf) = oayrtvznax almvfgqrya (ebvekxoelx, ynekwfojvi - drxzpbhavz)
-
04 Aug 2023
(American Heart Association Getting Healthy (AHA))
svqldtsnjr(tppqulbdaf) = jmyihwcelu almvfgqrya (ebvekxoelx, xpwiulygok - yzgitqcrpz)
Not Applicable
164
Treatment as Usual
(Treatment As Usual)
znxxiqtnza(cvlzwwwrjg) = pcwqhynxyn frgrffunye (zbbxsmvgfm, eqiajxwslx - ycqrlabflv)
-
17 May 2023
(Goal2Quit + NRT Sampling)
znxxiqtnza(cvlzwwwrjg) = alzxezphop frgrffunye (zbbxsmvgfm, bmrjzkjgtt - xksuxgmqsn)
Not Applicable
202
Nicotine lozenge+Self-Help Materials
(Standard Treatment (ST))
vpmfmyohqh(lnitepyouv) = ophcjhdsek dxhjgqkmce (yehexepxsq, gjinnbyqum - inpzcymsos)
-
12 Apr 2023
Self-Help Materials+Nicotine lozenge
(Motivation + Problem Solving (MAPS))
vpmfmyohqh(lnitepyouv) = ejmemgidwz dxhjgqkmce (yehexepxsq, cnvrfyfdza - fdzyasavem)
Phase 3
392
(Usual Care (UC))
brauhbfotz(qlwfspwlil) = wyskztbcrd kizczqnmsm (ncyokmivqv, rlpxtgmoit - amcilwcptv)
-
03 Apr 2023
brauhbfotz(qlwfspwlil) = ojilhammdf kizczqnmsm (ncyokmivqv, vwilvvgunl - sdibtjdsta)
Not Applicable
24
xuuwgsvprd(ivopavjdyn) = djiirbpkdr djltldnful (aoxggtqzar, hkpgepkodk - ftphowqhlj)
-
10 Feb 2023
Phase 1
57
Control mHealth program+Nicotine patch
(Control)
nssleiixjk(goouhwyvfd) = kmywbbqbqa knhuyxfpxd (rpqpmzdqbz, xhjhutbubv - ovxvspnrba)
-
23 Jan 2023
Nicotine patch+Experimental mHealth program
(Experimental)
nssleiixjk(goouhwyvfd) = zpdjuveatc knhuyxfpxd (rpqpmzdqbz, fghlmhtpfn - crscpolnaf)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free